Navigation Links
First-of-Its-Kind National Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia
Date:1/29/2008

The Majority of Respondents Feel Their Overall Health Affects Their

Recovery From Schizophrenia

WASHINGTON, Jan. 29 /PRNewswire/ -- Mental Health America today released results of the first national online survey to examine overall healthcare in mental health settings from the perspective of both people with schizophrenia and psychiatrists. Results showed that although both groups are aware of actions to improve overall health and quality of life, they are not discussing such actions to the extent possible.

Mental Health America conducted the survey in response to recent data showing that people with serious mental illnesses -- including schizophrenia -- die at least 25 years earlier than the general population, largely due to preventable medical conditions such as diabetes, cardiovascular disease and respiratory and infectious diseases. Nationwide, rates of chronic illnesses such as heart disease and diabetes are at epidemic levels. Nowhere is this public health dilemma more evident than in people with serious mental illnesses such as schizophrenia, who die at nearly twice the rate of the rest of the population from heart disease and diabetes.

"We should all be alarmed and outraged that the lives of people with schizophrenia are being cut short by 25 years," said David Shern, Ph.D., president and CEO of Mental Health America. "This survey tells us that mental health providers and people with schizophrenia must communicate more about issues like diet, exercise and medication side effects if we're to turn the tide of this public health crisis and extend the lives of the millions of Americans with schizophrenia."

While 40 percent of survey respondents have private health insurance, they still report significantly higher rates of chronic illnesses than the general population. 44% and 23% of all respondents reported being obese and having diabetes, respectively, compared to 26% and 8% of the general population.

Key survey findings include:

-- While many psychiatrists report asking or discussing general health

issues with their patients, 83% of psychiatrists cited lack of time

during patient visits as the main obstacle to providing overall care;

74% feel they are not as well equipped to address the patient's

overall health as are primary care physicians.

-- 82% of consumer respondents feel that treatment of their overall

health -- not just their mental illness -- is important to their

recovery. Yet nearly half expect their psychiatrist to focus

exclusively on their mental health (48%), rather than overall and

mental health.

Medication Side Effects

The survey also points to significant concerns about medication side effects. Experts suggest that some commonly-used mental health medications, namely second generation atypical anti-psychotics, which are associated with weight gain and other side effects, may be putting people with schizophrenia at much greater risk for obesity and diabetes. The survey found that:

-- 69% of people with schizophrenia reported that they have discontinued

use of medication due to side effects that negatively impacted their

quality of life. Almost 40% of consumers reported that the longest

they had continuously remained on one medication was less than a

year.

-- When choosing from a list of side effects considered when prescribing

antipsychotic medication, diabetes was most often cited by

prescribers, with 94% of psychiatrists considering it "extremely" or

"quite" important.

"When people with schizophrenia stop their medications, their mental health is jeopardized and they are not able to take the best care of themselves," said Joseph Parks, M.D., president of the Medical Director's Council of the National Association of State Mental Health Program Directors. "As psychiatrists, every one of us must redouble our efforts to protect the health and promote the wellbeing of our patients with schizophrenia. I think it's outrageous that over a quarter of psychiatrists don't see this as their responsibility to ensure patients receive appropriate care for all health problems."

About Schizophrenia

Schizophrenia is a chronic form of psychosis that affects approximately 2.4 million adults(i) and at least 1.25 million families(ii) in the United States. The disease is characterized by positive and negative symptoms such as hallucinations, delusions, poverty of speech, disorganized thought and emotional blunting.(iii) Severity of symptoms and the chronic pattern of schizophrenia often cause a high degree of disability for patients, impacting families, caregivers and communities.(iv) In 2002, schizophrenia cost the United States $62.7 billion.(v)

About the Survey

"Communicating About Health: A Mental Health America Survey of People with Schizophrenia and Providers" was conducted by International Communications Research, a leading independent research company. Surveys were conducted online between September 17 and October 12, 2007 among a sample of 250 adults with schizophrenia (ages 18 and older) who had been diagnosed by a qualified medical professional as a person with schizophrenia and 250 psychiatrists.

The group of consumers was provided by an online research panel that maintains a nationwide sample of respondents and rigorously checks the quality and validity of the sample. Average age of consumer respondents was 38, with a majority being female (56%), Caucasian (76%), employed -- paid or unpaid -- (52%) and from various incomes and geographic regions.

Physician respondents were comprised of practicing psychiatrists who treat people with schizophrenia and are members of a national, verified online research panel. Average years in practice for physician respondents was 12, with a majority being male (69%) and seeing 11 or more schizophrenia patients each month (81%). Respondents were from various geographic regions and worked in public, private and integrated health settings. The margin of error for the survey is +/- 6.2%.

The survey was funded by an unrestricted educational grant from Solvay Pharmaceuticals and Wyeth Pharmaceuticals and by an anonymous individual donation.

About Mental Health America

Mental Health America is the country's leading nonprofit dedicated to helping all people live mentally healthier lives. With our more than 320 affiliates nationwide, we represent a growing movement of Americans who promote mental wellness for the health and well-being of the nation -- everyday and in times of crisis.

(i) Regier DA, Narrow WE, Rae DS, et al. The de facto USmental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry. 1993;50:85-94.

(ii) Rose, L, Families of psychiatric patients: A critical review and future research directions. Archives of Psychiatric Nursing, 1996; 10(2), 67- 76.

(iii) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text revision. Washington, DC: American Psychiatric Publishing. 2000;297-312.

(iv) Rosenheck R, Cramer J, Jurgis G, et al. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. J Clin Psychiatry. 2000;61:671-676.

(v) Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psych. 2005;66(9):1122-1129.


'/>"/>
SOURCE Mental Health America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Benefitfocus(R) Unwraps First-of-Its-Kind Healthcare Media Studio
2. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
3. The American Nurses Association Hosts Conference on the National Database of Nursing Quality Indicators
4. National Institutes of Health funds new center for reproduction and infertility research at Illinois
5. National Business Coalition on Health Convenes Multi-Stakeholder Leadership Group to Address Value Based Purchasing Trends
6. Volunteer for National Suicide Prevention Agency Earns Cargill Award
7. February is National Pet Dental Health Month
8. MEDai Client Named Recipient of 2007 Malcolm Baldrige National Quality Award
9. AHIMA Launches National PHR Consumer Awareness Campaign
10. Senior Citizens Bureau Empowers Todays Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates
11. ...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National Win an MRI Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: